Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?

Ian Barrows, Ali Ramezani, Dominic S. Raj

Research output: Contribution to journalReview article

Abstract

Hypertension is considered as the most common risk factor for cardiovascular disease. Inflammatory processes link hypertension and cardiovascular disease, and participate in their pathophysiology. In recent years, there has been an increase in research focused on unraveling the role of inflammation and immune activation in development and maintenance of hypertension. Although inflammation is known to be associated with hypertension, whether inflammation is a cause or effect of hypertension remains to be elucidated. This review describes the recent studies that link inflammation and hypertension and demonstrate the involvement of oxidative stress and endothelial dysfunction—two of the key processes in the development of hypertension. Etiology of hypertension, including novel immune cell subtypes, cytokines, toll-like receptors, inflammasomes, and gut microbiome, found to be associated with inflammation and hypertension are summarized and discussed. Most recent findings in this field are presented with special emphasis on potential of anti-inflammatory drugs and statins for treatment of hypertension.

Original languageEnglish (US)
Pages (from-to)122-130
Number of pages9
JournalAdvances in Chronic Kidney Disease
Volume26
Issue number2
DOIs
StatePublished - Mar 1 2019
Externally publishedYes

Fingerprint

Crime
Immunity
Oxidative Stress
Hypertension
Inflammation
Cardiovascular Diseases
Inflammasomes
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Toll-Like Receptors
Anti-Inflammatory Agents
Maintenance
Cytokines

Keywords

  • Anti-inflammatory drugs
  • Hypertension
  • Immune activation
  • Inflammation
  • Oxidative stress

ASJC Scopus subject areas

  • Nephrology

Cite this

Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime? / Barrows, Ian; Ramezani, Ali; Raj, Dominic S.

In: Advances in Chronic Kidney Disease, Vol. 26, No. 2, 01.03.2019, p. 122-130.

Research output: Contribution to journalReview article

@article{1bdd96ba33dc4b808b9063f1ce466c66,
title = "Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?",
abstract = "Hypertension is considered as the most common risk factor for cardiovascular disease. Inflammatory processes link hypertension and cardiovascular disease, and participate in their pathophysiology. In recent years, there has been an increase in research focused on unraveling the role of inflammation and immune activation in development and maintenance of hypertension. Although inflammation is known to be associated with hypertension, whether inflammation is a cause or effect of hypertension remains to be elucidated. This review describes the recent studies that link inflammation and hypertension and demonstrate the involvement of oxidative stress and endothelial dysfunction—two of the key processes in the development of hypertension. Etiology of hypertension, including novel immune cell subtypes, cytokines, toll-like receptors, inflammasomes, and gut microbiome, found to be associated with inflammation and hypertension are summarized and discussed. Most recent findings in this field are presented with special emphasis on potential of anti-inflammatory drugs and statins for treatment of hypertension.",
keywords = "Anti-inflammatory drugs, Hypertension, Immune activation, Inflammation, Oxidative stress",
author = "Ian Barrows and Ali Ramezani and Raj, {Dominic S.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1053/j.ackd.2019.03.001",
language = "English (US)",
volume = "26",
pages = "122--130",
journal = "Advances in Chronic Kidney Disease",
issn = "1548-5595",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - Inflammation, Immunity, and Oxidative Stress in Hypertension—Partners in Crime?

AU - Barrows, Ian

AU - Ramezani, Ali

AU - Raj, Dominic S.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Hypertension is considered as the most common risk factor for cardiovascular disease. Inflammatory processes link hypertension and cardiovascular disease, and participate in their pathophysiology. In recent years, there has been an increase in research focused on unraveling the role of inflammation and immune activation in development and maintenance of hypertension. Although inflammation is known to be associated with hypertension, whether inflammation is a cause or effect of hypertension remains to be elucidated. This review describes the recent studies that link inflammation and hypertension and demonstrate the involvement of oxidative stress and endothelial dysfunction—two of the key processes in the development of hypertension. Etiology of hypertension, including novel immune cell subtypes, cytokines, toll-like receptors, inflammasomes, and gut microbiome, found to be associated with inflammation and hypertension are summarized and discussed. Most recent findings in this field are presented with special emphasis on potential of anti-inflammatory drugs and statins for treatment of hypertension.

AB - Hypertension is considered as the most common risk factor for cardiovascular disease. Inflammatory processes link hypertension and cardiovascular disease, and participate in their pathophysiology. In recent years, there has been an increase in research focused on unraveling the role of inflammation and immune activation in development and maintenance of hypertension. Although inflammation is known to be associated with hypertension, whether inflammation is a cause or effect of hypertension remains to be elucidated. This review describes the recent studies that link inflammation and hypertension and demonstrate the involvement of oxidative stress and endothelial dysfunction—two of the key processes in the development of hypertension. Etiology of hypertension, including novel immune cell subtypes, cytokines, toll-like receptors, inflammasomes, and gut microbiome, found to be associated with inflammation and hypertension are summarized and discussed. Most recent findings in this field are presented with special emphasis on potential of anti-inflammatory drugs and statins for treatment of hypertension.

KW - Anti-inflammatory drugs

KW - Hypertension

KW - Immune activation

KW - Inflammation

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=85064560996&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064560996&partnerID=8YFLogxK

U2 - 10.1053/j.ackd.2019.03.001

DO - 10.1053/j.ackd.2019.03.001

M3 - Review article

C2 - 31023446

AN - SCOPUS:85064560996

VL - 26

SP - 122

EP - 130

JO - Advances in Chronic Kidney Disease

JF - Advances in Chronic Kidney Disease

SN - 1548-5595

IS - 2

ER -